WallStreetZenWallStreetZen

NASDAQ: IDYA
Ideaya Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IDYA

Based on 8 analysts offering 12 month price targets for Ideaya Biosciences Inc

Min Forecast
$35.00-4.58%
Avg Forecast
$52.38+42.79%
Max Forecast
$65.00+77.21%

Should I buy or sell IDYA stock?

Based on 8 analysts offering ratings for Ideaya Biosciences Inc.

Strong Buy
Strong Buy
4 analysts 50%
Buy
3 analysts 37.5%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IDYA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IDYA as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their IDYA stock forecasts and price targets.

IDYA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-05
lockedlocked$00.00+00.00%2026-08-05
lockedlocked$00.00+00.00%2026-07-07
lockedlocked$00.00+00.00%2026-05-07
lockedlocked$00.00+00.00%2026-04-14
Wells Fargo
Top 5%
96
Strong BuyMaintains$48.00+30.86%2026-04-14
Guggenheim
Top 44%
57
Strong BuyMaintains$54.00+47.22%2026-04-14
Citigroup
Top 5%
96
Strong BuyMaintains$65.00+77.21%2026-02-19Find out why

1 of 1

Forecast return on equity

Is IDYA forecast to generate an efficient return?

Company
-7.42%
Industry
74.04%
Market
168.87%
IDYA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IDYA forecast to generate an efficient return on assets?

Company
-6.8%
Industry
38.27%
IDYA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IDYA earnings per share forecast

What is IDYA's earnings per share in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
-$4.44
Avg 2 year Forecast
-$3.96
Avg 3 year Forecast
-$3.23

IDYA revenue forecast

What is IDYA's revenue in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$36.1M-84.57%
Avg 2 year Forecast
$121.2M-48.25%
Avg 3 year Forecast
$215.4M-8.01%
IDYA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IDYA revenue growth forecast

How is IDYA forecast to perform vs Biotechnology companies and vs the US market?

Company
-2.99%
Industry
32.48%
Market
13.48%
IDYA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IDYA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IDYA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IDYA$36.68$52.38+42.79%Strong Buy
VCYT$42.60$54.25+27.35%Buy
RCUS$28.86$38.33+32.82%Buy
ABCL$10.97$14.60+33.09%Strong Buy
CLDX$42.61$58.10+36.35%Strong Buy
View Top Biotech Stocks

Ideaya Biosciences Stock Forecast FAQ

Is Ideaya Biosciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: IDYA) stock is to Strong Buy IDYA stock.

Out of 8 analysts, 4 (50%) are recommending IDYA as a Strong Buy, 3 (37.5%) are recommending IDYA as a Buy, 1 (12.5%) are recommending IDYA as a Hold, 0 (0%) are recommending IDYA as a Sell, and 0 (0%) are recommending IDYA as a Strong Sell.

If you're new to stock investing, here's how to buy Ideaya Biosciences stock.

What is IDYA's earnings growth forecast for 2026-2028?

(NASDAQ: IDYA) Ideaya Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.75%.

Ideaya Biosciences's earnings in 2026 is -$175,020,000.On average, 17 Wall Street analysts forecast IDYA's earnings for 2026 to be -$428,046,649, with the lowest IDYA earnings forecast at -$472,798,472, and the highest IDYA earnings forecast at -$353,585,714. On average, 16 Wall Street analysts forecast IDYA's earnings for 2027 to be -$382,522,910, with the lowest IDYA earnings forecast at -$431,192,206, and the highest IDYA earnings forecast at -$323,191,527.

In 2028, IDYA is forecast to generate -$311,902,257 in earnings, with the lowest earnings forecast at -$406,606,686 and the highest earnings forecast at -$135,558,076.

What is IDYA's revenue growth forecast for 2026-2028?

(NASDAQ: IDYA) Ideaya Biosciences's forecast annual revenue growth rate of -2.99% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.

Ideaya Biosciences's revenue in 2026 is $234,127,000.On average, 18 Wall Street analysts forecast IDYA's revenue for 2026 to be $3,486,840,483, with the lowest IDYA revenue forecast at $620,330,893, and the highest IDYA revenue forecast at $8,662,343,426. On average, 16 Wall Street analysts forecast IDYA's revenue for 2027 to be $11,689,700,987, with the lowest IDYA revenue forecast at $5,673,581,659, and the highest IDYA revenue forecast at $17,398,983,755.

In 2028, IDYA is forecast to generate $20,781,905,064 in revenue, with the lowest revenue forecast at $11,111,728,977 and the highest revenue forecast at $37,458,182,584.

What is IDYA's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: IDYA) forecast ROA is -6.8%, which is lower than the forecast US Biotechnology industry average of 38.27%.

What is IDYA's Price Target?

According to 8 Wall Street analysts that have issued a 1 year IDYA price target, the average IDYA price target is $52.38, with the highest IDYA stock price forecast at $65.00 and the lowest IDYA stock price forecast at $35.00.

On average, Wall Street analysts predict that Ideaya Biosciences's share price could reach $52.38 by Aug 5, 2027. The average Ideaya Biosciences stock price prediction forecasts a potential upside of 42.79% from the current IDYA share price of $36.68.

What is IDYA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IDYA) Ideaya Biosciences's current Earnings Per Share (EPS) is -$1.92. On average, analysts forecast that IDYA's EPS will be -$4.44 for 2026, with the lowest EPS forecast at -$4.90, and the highest EPS forecast at -$3.66. On average, analysts forecast that IDYA's EPS will be -$3.96 for 2027, with the lowest EPS forecast at -$4.47, and the highest EPS forecast at -$3.35. In 2028, IDYA's EPS is forecast to hit -$3.23 (min: -$4.21, max: -$1.40).

What is IDYA's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: IDYA) forecast ROE is -7.42%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.